{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:21:52Z","timestamp":1767964912043,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.4158\/ep-2019-0514","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T18:30:44Z","timestamp":1579717844000},"page":"612-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characteristics of Graves Disease in HIV-Infected Patients on Antiretroviral Therapy"],"prefix":"10.1016","volume":"26","author":[{"given":"Vitvala","family":"Jariyawattanarat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somnuek","family":"Sungkanuparph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chutinorn","family":"Sriphrapradang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0514_bb0010","first-page":"393","volume":"22","author":"Teeraananchai","year":"2017","journal-title":"Life expectancy after initiation of combination antiretroviral therapy in Thailand"},{"key":"10.4158\/EP-2019-0514_bb0015","first-page":"251","volume":"10","author":"Muller","year":"2010","journal-title":"Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis"},{"key":"10.4158\/EP-2019-0514_bb0020","first-page":"601","volume":"22","author":"Murdoch","year":"2008","journal-title":"Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study"},{"key":"10.4158\/EP-2019-0514_bb0025","first-page":"850","volume":"13","author":"Iordache","year":"2014","journal-title":"Autoimmune diseases in HIV-infected patients: 52 cases and literature review"},{"key":"10.4158\/EP-2019-0514_bb0030","first-page":"98","volume":"84","author":"Chen","year":"2005","journal-title":"Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease"},{"key":"10.4158\/EP-2019-0514_bb0035","first-page":"31","volume":"28","author":"Sheikh","year":"2014","journal-title":"Graves' disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4(+) T-cell recovery"},{"key":"10.4158\/EP-2019-0514_bb0040","first-page":"147","volume":"9","author":"Tomer","year":"2014","journal-title":"Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics"},{"key":"10.4158\/EP-2019-0514_bb0045","first-page":"564","volume":"32","author":"Hsu","year":"2016","journal-title":"Short communication: hyperthyroidism in human immunodeficiency virus patients on combined antiretroviral therapy: case series and literature review"},{"key":"10.4158\/EP-2019-0514_bb0050","first-page":"2619695","volume":"2017","author":"Sriussadaporn","year":"2017","journal-title":"Efficacy of once daily versus divided daily administration of low daily dosage (15 mg\/day) of methimazole in the induction of euthyroidism in Graves' hyperthyroidism: a randomized controlled study"},{"key":"10.4158\/EP-2019-0514_bb0055","first-page":"488","volume":"45","author":"Hoffmann","year":"2007","journal-title":"Thyroid function abnormalities in HIV-infected patients"},{"key":"10.4158\/EP-2019-0514_bb0060","first-page":"2195","volume":"32","author":"Harslof","year":"2018","journal-title":"No evidence of increased risk of thyroid dysfunction in well treated people living with HIV"},{"key":"10.4158\/EP-2019-0514_bb0065","first-page":"22","volume":"8","author":"Madge","year":"2007","journal-title":"No association between HIV disease and its treatment and thyroid function"},{"key":"10.4158\/EP-2019-0514_bb0070","first-page":"768","volume":"78","author":"Nystr\u00f6m","year":"2013","journal-title":"Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003\u20132005"},{"key":"10.4158\/EP-2019-0514_bb0075","first-page":"102","volume":"19","author":"Knysz","year":"2006","journal-title":"Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review"},{"key":"10.4158\/EP-2019-0514_bb0080","first-page":"753","volume":"15","author":"Lockshin","year":"2006","journal-title":"Sex differences in autoimmune disease"},{"key":"10.4158\/EP-2019-0514_bb0085","first-page":"1343","volume":"26","author":"Ross","year":"2016","journal-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis"},{"key":"10.4158\/EP-2019-0514_bb0090","first-page":"167","volume":"7","author":"Kahaly","year":"2018","journal-title":"2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism"},{"key":"10.4158\/EP-2019-0514_bb0095","first-page":"127","volume":"50","author":"Maugendre","year":"1999","journal-title":"Antithyroid drugs and Graves' disease--prospective randomized assessment of long-term treatment"},{"key":"10.4158\/EP-2019-0514_bb0100","first-page":"CD003420","volume":"1","author":"Abraham","year":"2010","journal-title":"Antithyroid drug regimen for treating Graves' hyperthyroidism"},{"key":"10.4158\/EP-2019-0514_bb0105","first-page":"1443","volume":"98","author":"Tanda","year":"2013","journal-title":"Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center"},{"key":"10.4158\/EP-2019-0514_bb0110","first-page":"4254","volume":"85","author":"Jubault","year":"2000","journal-title":"Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients"},{"key":"10.4158\/EP-2019-0514_bb0115","first-page":"743597","volume":"2011","author":"Rasul","year":"2011","journal-title":"Graves' disease as a manifestation of immune reconstitution in HIV-infected individuals after initiation of highly active antiretroviral therapy"},{"key":"10.4158\/EP-2019-0514_bb0120","first-page":"35","volume":"162","author":"Rugge","year":"2015","journal-title":"Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force"},{"key":"10.4158\/EP-2019-0514_bb0125","first-page":"219","volume":"43","author":"Scappaticcio","year":"2020","journal-title":"Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis"},{"key":"10.4158\/EP-2019-0514_bb0130","first-page":"173","volume":"8","author":"Muller","year":"2019","journal-title":"2019 European Thyroid Association Guidelines on the management of thyroid dysfunction following immune reconstitution therapy"},{"key":"10.4158\/EP-2019-0514_bb0135","first-page":"4549","volume":"97","author":"Burch","year":"2012","journal-title":"A 2011 survey of clinical practice patterns in the management of Graves' disease"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20300136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20300136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:07:49Z","timestamp":1761516469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20300136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1530891X20300136"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0514","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Graves Disease in HIV-Infected Patients on Antiretroviral Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}